We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
8 hedge funds and large institutions have $104K invested in Decoy Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
115% more capital invested
Capital invested by funds: $48.4K → $104K (+$55.6K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
60% more funds holding
Funds holding: 5 → 8 (+3)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HF
HRT Financial
New York
|
+$24.8K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$13.1K |
| 3 |
Goldman Sachs
New York
|
+$13.1K |
| 4 |
Barclays
London,
United Kingdom
|
+$6.33K |
| 5 |
Citigroup
New York
|
+$4.64K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12.2K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$11.6K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$141 |